Abstract
Vascular cells and leukocytes, involved in the development of atherosclerosis, produce cytokines and/or reactive oxygen species (ROS) and matrix metalloproteinases (MMPs) implicated in cell mobility. We investigated by co-culture experiments the effects of human coronary smooth muscle cells (HCSMC) on MMPs characteristics and mobility of neutrophil-like dimethyl sulfoxide-differentiated HL60 cells (≠HL60). The effects of superoxide dismutase (SOD) and catalase were also analyzed. All the studied MMP2 characteristics remained unchanged. HCSMC stimulated MMP9 protein level, activity and mobility of ≠HL60 cells and expressed and secreted a variety of cytokines implicated in atherosclerosis. SOD and catalase increased MMP9 expression, protein level and activity of ≠HL60, but migration of ≠HL60 cells was only decreased by catalase, demonstrating that ROS are more efficient in modulating MMP9 activity of ≠HL60 than their mobility. Finally, HCSMC being able to stimulate ≠HL60, their co-cultures may represent an in vitro approach to study cellular interactions occurring in vivo during atherosclerosis.
Similar content being viewed by others
References
Ross, R. 1999. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340:115–126.
Hansson, G. K. 2001. Regulation of immune mechanisms in atherosclerosis. Ann. N. Y. Acad. Sci. 947:157–165.
Libby, P. 2002. Inflammation in atherosclerosis. Nature 420:868–874.
Newby, A. C. 2005. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85:1–31.
Kai, H., H. Ikeda, H. Yasukawa, M. Kai, Y. Seki, F. Kuwahara, T. Ueno, K. Sugi, and T. Imaizumi. 1998. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 32:368–372.
Ferroni, P., S. Basili, F. Martini, C. M. Cardarello, F. Ceci, M. Di Franco, G. Bertazzoni, P. P. Gazzaniga, and C. Alessandri. 2003. Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation. J. Investig. Med. 51:295–300.
Bueb, J.-L., D. Zardini, E. Tschirhart, M. Gloesener, G. Gilson, and D. R. Wagner. 2003. Increased levels of Matrix Metalloproteinase-9 in patients with acute myocardial infarction: no correlation with C-Reactive Protein. J. Am. Coll. Cardiol. S265233.
Robertson, L., L. Grip, L. Mattsson Hulten, J. Hulthe, and O. Wiklund. 2007. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention. J. Intern. Med. 262:659–667.
Mauviel, A. 1993. Cytokine regulation of metalloproteinase gene expression. J. Cell. Biochem. 53:288–295.
Sato, H., T. Takino, T. Kinoshita, K. Imai, Y. Okada, W. G. Stetler Stevenson, and M. Seiki. 1996. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett. 385:238–240.
Denhardt, D. T., B. Feng, D. R. Edwards, E. T. Cocuzzi, and U. M. Malyankar. 1993. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol. Ther. 59:329–341.
Chakrabarti, S., and K. D. Patel. 2005. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J. Leukoc. Biol. 78:279–288.
Rajagopalan, S., X. P. Meng, S. Ramasamy, D. G. Harrison, and Z. S. Galis. 1996. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98:2572–2579.
Lee, E., A. J. Grodzinsky, P. Libby, S. K. Clinton, M. W. Lark, and R. T. Lee. 1995. Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. Arterioscler. Thromb. Vasc. Biol. 15:2284–2289.
Vanderlaan, P. A., and C. A. Reardon. 2005. Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J. Lipid Res. 46:829–838.
Naruko, T., M. Ueda, K. Haze, A. C. van der Wal, C. M. van der Loos, A. Itoh, R. Komatsu, Y. Ikura, M. Ogami, Y. Shimada, S. Ehara, M. Yoshiyama, K. Takeuchi, J. Yoshikawa, and A. E. Becker. 2002. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106:2894–2900.
Collins, S. J. 1987. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70:1233–1244.
Bréchard, S., J.-L. Bueb, and E. J. Tschirhart. 2005. Interleukin-8 primes oxidative burst in neutrophil-like HL-60 through changes in cytosolic calcium. Cell Calcium 37:531–540.
Bréchard, S., A. Brunello, J.-L. Bueb, and E. J. Tschirhart. 2006. Modulation by cADPr of Ca2+ mobilization and oxidative response in dimethylsulfoxide- or retinoic acid-differentiated HL-60 cells. Biochim. Biophys. Acta. 1763:129–136.
Valentin, F., J.-L. Bueb, C. Capdeville-Atkinson, and E. Tschirhart. 2001. Rac-1-mediated O2 - secretion requires Ca2+ influx in neutrophil-like HL-60 cells. Cell Calcium 29:409–415.
Galis, Z. S., M. Muszynski, G. K. Sukhova, E. Simon-Morrissey, E. N. Unemori, M. W. Lark, E. Amento, and P. Libby. 1994. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75:181–189.
Ries, C., H. Kolb, and P. E. Petrides. 1994. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 83:3638–3646.
Sawa, Y., H. Ichikawa, K. Kagisaki, T. Ohata, and H. Matsuda. 1998. Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J. Thorac. Cardiovasc. Surg. 116:511–517.
Ridker, P. M., N. Rifai, M. J. Stampfer, and C. H. Hennekens. 2000. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767–1772.
Schonbeck, U., and P. Libby. 2001. CD40 signaling and plaque instability. Circ. Res. 89:1092–1103.
Dreier, R., S. Wallace, S. Fuchs, P. Bruckner, and S. Grassel. 2001. Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9). J. Cell. Sci. 114:3813–3822.
Christopherson, K. , and R. Hromas. 2001. Chemokine regulation of normal and pathologic immune responses. Stem Cells 19:388–396.
Miller, L. S., E. M. Pietras, L. H. Uricchio, K. Hirano, S. Rao, H. Lin, R. M. O’Connell, Y. Iwakura, A. L. Cheung, G. Cheng, and R. L. Modlin. 2007. Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J. Immunol. 179:6933–6942.
Colditz, I., R. Zwahlen, B. Dewald, and M. Baggiolini. 1989. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am. J. Pathol. 134:755–760.
Gouwy, M., S. Struyf, J. Catusse, P. Proost, and J. Van Damme. 2004. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration. J. Leukoc. Biol. 76:185–194.
Siwik, D. A., P. J. Pagano, and W. S. Colucci. 2001. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 280:C53–C60.
Oishi, K., and K. Machida. 1997. Inhibition of neutrophil apoptosis by antioxidants in culture medium. Scand. J. Immunol. 45:21–27.
Ali, M. H., S. A. Schlidt, N. S. Chandel, K. L. Hynes, P. T. Schumacker, and B. L. Gewertz. 1999. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am. J. Physiol. 277:L1057–L1065.
Hashimoto, S., Y. Gon, K. Matsumoto, I. Takeshita, and T. Horie. 2001. N-acetylcysteine attenuates TNF-alpha-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells. Br. J. Pharmacol. 132:270–276.
Van Wart, H. E., and H. Birkedal-Hansen. 1990. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U. S. A. 87:5578–5582.
Nishio, E., and Y. Watanabe. 1997. The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br. J. Pharmacol. 121:665–670.
Shim, H., E. Shim, H. Lee, J. Hahn, D. Kang, Y. S. Lee, and D. Jeoung. 2006. CAGE, a novel cancer/testis antigen gene, promotes cell motility by activation ERK and p38 MAPK and downregulating ROS. Mol. Cells 21:367–375.
Lardot, C., F. Broeckaert, D. Lison, J. P. Buchet, and R. Lauwerys. 1996. Exogenous catalase may potentiate oxidant-mediated lung injury in the female Sprague–Dawley rat. J. Toxicol. Environ. Health 47:509–522.
Simonson, S. G., K. E. Welty-Wolf, Y. C. Huang, D. E. Taylor, S. P. Kantrow, M. S. Carraway, J. D. Crapo, and C. A. Piantadosi. 1997. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. I. Physiology and biochemistry. J. Appl. Physiol. 83:550–558.
Raineri, I., E. J. Carlson, R. Gacayan, S. Carra, T. D. Oberley, T. T. Huang, and C. J. Epstein. 2001. Strain-dependent high-level expression of a transgene for manganese superoxide dismutase is associated with growth retardation and decreased fertility. Free Radic. Biol. Med. 31:1018–1030.
Rando, T. A., R. S. Crowley, E. J. Carlson, C. J. Epstein, and P. K. Mohapatra. 1998. Overexpression of copper/zinc superoxide dismutase: a novel cause of murine muscular dystrophy. Ann. Neurol. 44:381–386.
Chen, X., H. Liang, H. Van Remmen, J. Vijg, and A. Richardson. 2004. Catalase transgenic mice: characterization and sensitivity to oxidative stress. Arch. Biochem. Biophys. 422:197–210.
Acknowledgments
This work was supported by the Université du Luxembourg and by a research grant (BFR 03/072) from the Ministère de la Culture, de la Recherche et de l’Enseignement Supérieur. We thank Alexandre Salsmann for the critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bernard, Y., Melchior, C., Tschirhart, E. et al. Co-cultures of Human Coronary Smooth Muscle Cells and Dimethyl Sulfoxide-differentiated HL60 Cells Upregulate ProMMP9 Activity and Promote Mobility—Modulation By Reactive Oxygen Species. Inflammation 31, 287–298 (2008). https://doi.org/10.1007/s10753-008-9077-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-008-9077-z